Amgen

Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?
Motley Fool
Sun, 02/2/20 - 11:54 pm
Amgen
earnings
M&A
Asia
Amgen, Pfizer biosimilar sales pressure top drugs
BioPharma Dive
Fri, 01/31/20 - 12:13 pm
biosimilars
Amgen
Pfizer
Roche
Amgen Revenue Slipped 1% in the Fourth Quarter
Motley Fool
Thu, 01/30/20 - 09:25 pm
Amgen
earnings
Big pharma backed away from brain drugs. Is a return in sight?
BioPharma Dive
Wed, 01/29/20 - 11:55 pm
Big Pharma
Neuroscience
AstraZeneca
Bristol-Myers Squibb
GSK
Pfizer
Amgen
Amgen wades deeper into Asia with full control of an Astellas Japanese JV
Fierce Pharma
Thu, 01/23/20 - 12:12 pm
Amgen
Astellas
Japan
BeiGene
China
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans
BioSpace
Wed, 01/15/20 - 10:59 am
drug pricing
Roche
Eli Lilly
Amgen
Alnylam
Sanofi
Merck, Lilly and Amgen square off in appeals court over drug pricing in TV ads
Fierce Pharma
Mon, 01/13/20 - 10:47 am
Merck
Eli Lilly
Amgen
HHS
drug pricing
television ads
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
Sat, 01/11/20 - 11:02 pm
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
Two Big Drug Flops Show How Health-Care Economics Have Changed
Bloomberg
Fri, 01/10/20 - 10:34 am
drug pricing
Sanofi
Amgen
Praluent
Repatha
Amgen to Sell Cancer Drugs in China Thanks to $2.7B Deal with BeiGene
Xtalks
Fri, 01/3/20 - 10:51 pm
Amgen
BeiGene
oncology
China
Is there a future for pharma in neuro?
Fierce Biotech
Sun, 12/22/19 - 12:25 am
Neuroscience
R&D
Eli Lilly
Amgen
GSK
Novartis
Amgen, Allergan join Rituxan biosimilar challenge with FDA filing
Pharmaforum
Fri, 12/20/19 - 12:15 pm
Amgen
Allergan
biosimilar
Roche
Rituxan
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
Xconomy
Thu, 12/12/19 - 11:02 am
osteoporosis
Amgen
Europe
romosozumab
Evenity
Amgen rejigs Bay Area presence with deal for new R&D facility
Fierce Biotech
Tue, 12/10/19 - 10:14 am
Amgen
Bay Area
San Francisco
R&D
ASH: Amgen's BiTE stalls multiple myeloma relapse in mice in combo with BMS' Revlimid
Fierce Biotech
Mon, 12/9/19 - 09:53 am
Amgen
ASH2019
bispecific antibodies
AMG 701
Multiple Myeloma
3 Biotechs Facing FDA Approvals by Year's End
Motley Fool
Mon, 12/9/19 - 09:45 am
FDA
Amgen
Vascepa
Allergan
migraines
ubrogepant
Intra-Cellular Therapies
lumateperone
schizophrenia
4 FDA Dates Biotech Investors Should Circle in December
Motley Fool
Sun, 12/8/19 - 10:24 pm
FDA
Amgen
anti-inflammatories
ABP710
Bausch Health Companies
acne
IDP-123
Intra-Cellular Therapies
lumateperone
schizophrenia
Vascepa
Amarin
Top 7 Companies in Biotech Beach by Revenue
BioSpace
Thu, 12/5/19 - 10:15 am
Biotech Beach
San Diego
California
Amgen
Neurocrine
Acadia Pharmaceuticals
Retrophin
Tocagen
Mirati Therapeutics
AnaptysBio
Amgen snags another Enbrel outcomes-based payment deal as it seeks to prop up aging blockbuster
Fierce Pharma
Wed, 12/4/19 - 11:18 pm
Amgen
Enbrel
Abarca
PBMs
rheumatoid arthritis

Pages